Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Ibrutinib and idelalisib in the management of CLL-associated autoimmune cytopenias: a study from the FILO group.

Quinquenel A, Godet S, Dartigeas C, Ysebaert L, Dupuis J, Ohanyan H, Collignon A, Gilardin L, Lepretre S, Dilhuydy MS, Vignon M, de Guibert S, Dmytruk N, Durot E, Ghez D, Roos Weil D, Béné MC, Toussaint E, Merabet F, Lévy V, Delmer A, Aurran T.

Am J Hematol. 2019 Jul;94(7):E183-E185. doi: 10.1002/ajh.25480. Epub 2019 Apr 11. No abstract available.

PMID:
30945328
2.

Anti-PD-1 immunotherapy in combination with sequential involved-site radiotherapy in heavily pretreated refractory Hodgkin lymphoma.

Quéro L, Gilardin L, Fumagalli I, Martin V, Guillerm S, Bauduceau O, Kirova YM, Hennequin C, Brice P.

Cancer Radiother. 2019 Apr;23(2):132-137. doi: 10.1016/j.canrad.2018.05.002. Epub 2019 Feb 4.

PMID:
30733172
3.

L’arrivée de l’immunothérapie dans le lymphome de Hodgkin.

Gilardin L, Amorim S, Bernard S, Ravdan O, Thieblemont C, Brice P.

Bull Cancer. 2018 Dec;105 Suppl 1:S50-S58. doi: 10.1016/S0007-4551(18)30390-4. Review. French.

PMID:
30595199
4.

Intravenous immunoglobulin induces IL-4 in human basophils by signaling through surface-bound IgE.

Galeotti C, Stephen-Victor E, Karnam A, Das M, Gilardin L, Maddur MS, Wymann S, Vonarburg C, Chevailler A, Dimitrov JD, Benveniste O, Bruhns P, Kaveri SV, Bayry J.

J Allergy Clin Immunol. 2019 Aug;144(2):524-535.e8. doi: 10.1016/j.jaci.2018.10.064. Epub 2018 Dec 7.

5.

Anti-ADAMTS13 Autoantibodies against Cryptic Epitopes in Immune-Mediated Thrombotic Thrombocytopenic Purpura.

Roose E, Vidarsson G, Kangro K, Verhagen OJHM, Mancini I, Desender L, Pareyn I, Vandeputte N, Vandenbulcke A, Vendramin C, Schelpe AS, Voorberg J, Azerad MA, Gilardin L, Scully M, Dierickx D, Deckmyn H, De Meyer SF, Peyvandi F, Vanhoorelbeke K.

Thromb Haemost. 2018 Oct;118(10):1729-1742. doi: 10.1055/s-0038-1669459. Epub 2018 Sep 20.

6.

Subacute inflammatory demyelinating polyradiculoneuropathy complicating relapsing Hodgkin lymphoma: another immune-related adverse event of the anti-PD1 therapy?

Barp A, Gilardin L, Afanasiev V, Delorme C, Viala K, Bernard S, Brice P, Psimaras D, Lenglet T.

Leuk Lymphoma. 2019 Feb;60(2):547-549. doi: 10.1080/10428194.2018.1485912. Epub 2018 Jul 22. No abstract available.

PMID:
30033838
7.

Symptomatic muscular sarcoidosis: Lessons from a nationwide multicenter study.

Cohen Aubart F, Abbara S, Maisonobe T, Cottin V, Papo T, Haroche J, Mathian A, Pha M, Gilardin L, Hervier B, Soussan M, Morlat P, Nunes H, Benveniste O, Amoura Z, Valeyre D.

Neurol Neuroimmunol Neuroinflamm. 2018 Mar 16;5(3):e452. doi: 10.1212/NXI.0000000000000452. eCollection 2018 May.

8.

Complement C3 is a novel modulator of the anti-factor VIII immune response.

Rayes J, Ing M, Delignat S, Peyron I, Gilardin L, Vogel CW, Fritzinger DC, Frémeaux-Bacchi V, Kaveri SV, Roumenina LT, Lacroix-Desmazes S.

Haematologica. 2018 Feb;103(2):351-360. doi: 10.3324/haematol.2017.165720. Epub 2017 Nov 16.

9.

The ADAMTS131239-1253 peptide is a dominant HLA-DR1-restricted CD4+ T-cell epitope.

Gilardin L, Delignat S, Peyron I, Ing M, Lone YC, Gangadharan B, Michard B, Kherabi Y, Sharma M, Pashov A, Latouche JB, Hamieh M, Toutirais O, Loiseau P, Galicier L, Veyradier A, Kaveri S, Maillère B, Coppo P, Lacroix-Desmazes S.

Haematologica. 2017 Nov;102(11):1833-1841. doi: 10.3324/haematol.2015.136671. Epub 2017 Jul 27.

10.

High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody.

Allenbach Y, Keraen J, Bouvier AM, Jooste V, Champtiaux N, Hervier B, Schoindre Y, Rigolet A, Gilardin L, Musset L, Charuel JL, Boyer O, Jouen F, Drouot L, Martinet J, Stojkovic T, Eymard B, Laforêt P, Behin A, Salort-Campana E, Fain O, Meyer A, Schleinitz N, Mariampillai K, Grados A, Benveniste O.

Brain. 2016 Aug;139(Pt 8):2131-5. doi: 10.1093/brain/aww054. Epub 2016 Apr 17.

PMID:
27086869
11.

Generation of Catalytic Antibodies Is an Intrinsic Property of an Individual's Immune System: A Study on a Large Cohort of Renal Transplant Patients.

Mahendra A, Peyron I, Thaunat O, Dollinger C, Gilardin L, Sharma M, Wootla B, Rao DN, Padiolleau-Lefevre S, Boquet D, More A, Varadarajan N, Kaveri SV, Legendre C, Lacroix-Desmazes S.

J Immunol. 2016 May 15;196(10):4075-81. doi: 10.4049/jimmunol.1403005. Epub 2016 Apr 11.

12.

Intravenous immunoglobulin as clinical immune-modulating therapy.

Gilardin L, Bayry J, Kaveri SV.

CMAJ. 2015 Mar 3;187(4):257-264. doi: 10.1503/cmaj.130375. Epub 2015 Feb 9. Review. No abstract available.

13.

Intravenous immunoglobulin-induced IL-33 is insufficient to mediate basophil expansion in autoimmune patients.

Sharma M, Schoindre Y, Hegde P, Saha C, Maddur MS, Stephen-Victor E, Gilardin L, Lecerf M, Bruneval P, Mouthon L, Benveniste O, Kaveri SV, Bayry J.

Sci Rep. 2014 Jul 11;4:5672. doi: 10.1038/srep05672.

14.

Interferon-α inhibition by intravenous immunoglobulin is independent of modulation of the plasmacytoid dendritic cell population in the circulation: comment on the article by Wiedeman et al.

Sharma M, Saha C, Schoindre Y, Gilardin L, Benveniste O, Kaveri SV, Bayry J.

Arthritis Rheumatol. 2014 Aug;66(8):2308-9. doi: 10.1002/art.38683. No abstract available.

15.

Predictive immunogenicity of Refacto AF.

Delignat S, Repessé Y, Gilardin L, Dimitrov JD, Lone YC, Kaveri SV, Lacroix-Desmazes S.

Haemophilia. 2014 Jul;20(4):486-92. doi: 10.1111/hae.12348. Epub 2013 Dec 30.

PMID:
24372710
16.

In silico calculated affinity of FVIII-derived peptides for HLA class II alleles predicts inhibitor development in haemophilia A patients with missense mutations in the F8 gene.

Pashov AD, Calvez T, Gilardin L, Maillère B, Repessé Y, Oldenburg J, Pavlova A, Kaveri SV, Lacroix-Desmazes S.

Haemophilia. 2014 Mar;20(2):176-84. doi: 10.1111/hae.12276. Epub 2013 Oct 14.

PMID:
24118514
17.

IVIg treatment reduces catalytic antibody titers of renal transplanted patients.

Mahendra A, Peyron I, Dollinger C, Gilardin L, Sharma M, Wootla B, Padiolleau-Lefevre S, Friboulet A, Boquet D, Legendre C, Kaveri SV, Thaunat O, Lacroix-Desmazes S.

PLoS One. 2013 Aug 15;8(8):e70731. doi: 10.1371/journal.pone.0070731. eCollection 2013.

18.

Peripheral T-cell lymphoma in HIV-infected patients: a study of 17 cases in the combination antiretroviral therapy era.

Gilardin L, Copie-Bergman C, Galicier L, Meignin V, Brière J, Timsit JF, Bouchaud O, Gaulard P, Oksenhendler E, Gérard L.

Br J Haematol. 2013 Jun;161(6):843-51. doi: 10.1111/bjh.12341. Epub 2013 Apr 18.

PMID:
23593987
19.

Kinetic profiles and management of hepatitis B virus reactivation in patients with immune-mediated inflammatory diseases.

Droz N, Gilardin L, Cacoub P, Berenbaum F, Wendling D, Godeau B, Piette AM, Dernis E, Ebbo M, Fautrel B, Le Guenno G, Mekinian A, Bernard-Chabert B, Costedoat-Chalumeau N, Descloux E, Michot JM, Radenne S, Rigolet A, Rivière S, Yvin JL, Thibault V, Thabut D, Pol S, Guillevin L, Mouthon L, Terrier B.

Arthritis Care Res (Hoboken). 2013 Sep;65(9):1504-14. doi: 10.1002/acr.21990. Review.

20.

[Coma of unknown cause in a 35-year-old man].

Gilardin L, Bavoux F, Roziers NB, Deutsch J, Mira JP, Grimaldi D, Foïs E.

Rev Med Interne. 2012 Aug;33(8):465-7. doi: 10.1016/j.revmed.2012.05.002. Epub 2012 Jun 19. French. No abstract available.

PMID:
22721645
21.

[Human immunodeficiency virus-associated thrombotic microangiopathies].

Gilardin L, Malak S, Schoindre Y, Galicier L, Veyradier A, Coppo P.

Rev Med Interne. 2012 May;33(5):259-64. doi: 10.1016/j.revmed.2011.11.015. Epub 2012 Jan 26. Review. French.

PMID:
22280852
22.

Pauci-immune crescentic glomerulonephritis associated with ANCA of IgA class.

Bollée G, Noël LH, Suarez F, Royal V, Gilardin L, de Serre NP, El-Ghoul B, Lesavre P, Alyanakian MA, Fakhouri F.

Am J Kidney Dis. 2009 Jun;53(6):1063-7. doi: 10.1053/j.ajkd.2008.10.039. Epub 2008 Dec 11.

PMID:
19084310

Supplemental Content

Loading ...
Support Center